103 related articles for article (PubMed ID: 14618108)
1. Cutaneous microvascular effects of mid-term hormone replacement therapy in healthy postmenopausal women: a prospective placebo controlled trial.
Chabbert-Buffet N; Bonnin P; Lévy B; Abdoucheli-Baudot N; Tribout L; Gaitz JP; Vayssairat M
J Mal Vasc; 2003 Oct; 28(4):190-3. PubMed ID: 14618108
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
[TBL] [Abstract][Full Text] [Related]
3. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
Prázný M; Fait T; Vrablik M
Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women.
Sator PG; Sator MO; Schmidt JB; Nahavandi H; Radakovic S; Huber JC; Hönigsmann H
Climacteric; 2007 Aug; 10(4):320-34. PubMed ID: 17653959
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women.
Eriksen EF; Langdahl B; Vesterby A; Rungby J; Kassem M
J Bone Miner Res; 1999 Jul; 14(7):1217-21. PubMed ID: 10404024
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
7. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
Kessel H; Kamp O; Kenemans P; Mijatovic V; van Baal WM; Visser CA; van der Mooren MJ
Am J Obstet Gynecol; 2001 Apr; 184(5):910-6. PubMed ID: 11303198
[TBL] [Abstract][Full Text] [Related]
8. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I
Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
[TBL] [Abstract][Full Text] [Related]
9. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
de Paula FJ; Soares JM; Haidar MA; de Lima GR; Baracat EC
Maturitas; 2007 Jan; 56(1):69-77. PubMed ID: 16822626
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
Kaya C; Cengiz SD; Cengiz B; Akgun G
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():62-7. PubMed ID: 17943541
[TBL] [Abstract][Full Text] [Related]
11. Impact of hormone replacement therapy on microvascular function in healthy and Type 2 diabetic postmenopausal women.
Gooding KM; MacLeod KM; Spyer G; Ewings P; Tooke JE; Shore AC
Diabet Med; 2005 May; 22(5):536-42. PubMed ID: 15842506
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study.
Taskin O; Muderrisoglu H; Akar M; Simsek M; Mendilcioglu I; Kursun S
Maturitas; 2004 Aug; 48(4):354-9. PubMed ID: 15283927
[TBL] [Abstract][Full Text] [Related]
13. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy.
Petri Nahas E; Nahás Neto J; De Luca L; Traiman P; Pontes A; Dalben I
Maturitas; 2004 Aug; 48(4):372-80. PubMed ID: 15283929
[TBL] [Abstract][Full Text] [Related]
14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of 17beta-estradiol over 3 months without progestin co-administration does not improve coronary flow reserve in post-menopausal women: a randomized placebo-controlled cross-over CMR study.
Schwitter J; Kozerke S; Bremerich J; Baltes C; Attenhofer Jost C; Birkhäuser M; Boesiger P; Buser P
J Cardiovasc Magn Reson; 2007; 9(4):665-72. PubMed ID: 17578722
[TBL] [Abstract][Full Text] [Related]
16. Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/kidney transplantation.
Eberl N; Piehlmeier W; Dachauer S; König A; Land W; Landgraf R
Diabetes Metab Res Rev; 2005; 21(6):525-32. PubMed ID: 15880479
[TBL] [Abstract][Full Text] [Related]
17. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women.
van Baal WM; Kenemans P; van der Mooren MJ; Kessel H; Emeis JJ; Stehouwer CD
Thromb Haemost; 1999 Jun; 81(6):925-8. PubMed ID: 10404769
[TBL] [Abstract][Full Text] [Related]
18. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial.
Snabes MC; Payne JP; Kopelen HA; Dunn JK; Young RL; Zoghbi WA
Obstet Gynecol; 1997 Mar; 89(3):332-9. PubMed ID: 9052580
[TBL] [Abstract][Full Text] [Related]
19. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
Phillips TJ; Symons J; Menon S;
J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
[TBL] [Abstract][Full Text] [Related]
20. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
